Clinical trial

Ambroxol as a Treatment for Parkinson's Disease Dementia

NCT02914366

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-11-01

PhasePHASE2

Study timeline

Study start (actual)2015-11-01Date precision: month

Registry last updated2024-02-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Disease Dementiaunresolved

Interventions

AmbroxolDRUG · verified · RxNorm: ambroxol

Sponsors & collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'slead sponsor

Weston Brain Institutecollaborator

Western University, Canadacollaborator

London Health Sciences Centrecollaborator

Mapped research locations

LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02914366 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.